‘Build Back Better Act’ drug pricing provisions weaken U.S. innovation ecosystem, hurt patients
Dr. Michelle McMurry-Heath, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement after the House of Representatives passed the Build […]